Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2003
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425007A Preparation of sulfonamides
06/18/2003CN1424999A Aminoalcohol derivatives
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424315A Ginkgo lactone compound and its preparation and medicinal composition containing it
06/18/2003CN1424313A Chuanxiong alkoxide derivative and its preparation and medicinal composition containing it and use thereof
06/18/2003CN1424312A Specific indole compound and its preparation and use in treating and preventing cancers
06/18/2003CN1424096A Composite red sage root micro-capsules for cardio-cerebral diseases and its preparing method
06/18/2003CN1424092A External applied medicinal liquor for treating legs phlebeurysma and production thereof
06/18/2003CN1424091A External applied medicinal liquor for treating angitis and production thereof
06/18/2003CN1424089A Composite red sage root spray for cardio-cerebral diseases and its preparing method
06/18/2003CN1424088A Composite red sage root granules for cardio-cerebral diseases and its preparing method
06/18/2003CN1424081A Medicine for acute ischemic apoplexy and its preparing method
06/18/2003CN1424080A Medicine for acute cerebral hemorrhage and its preparing method
06/18/2003CN1424066A Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof
06/18/2003CN1424050A Capsules of rana amurensis ovary
06/18/2003CN1424042A Crataegus leaves flavone tablets and their preparing method
06/18/2003CN1424041A Kakonein preparations and their production
06/18/2003CN1424035A Lyophilized composition of nimodipine
06/18/2003CN1424032A Capsule agent with grape-seed extracts as raw material
06/18/2003CN1424031A Preparation containing Gingkolactone and its producing process
06/18/2003CN1424025A Medicine against spinal canal restenosis and use thereof
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111428C Compound ginkgo health product and preparing method
06/18/2003CN1111424C Ginseng astragalus capsule for curing hemiplegia
06/18/2003CN1111422C Injection for treating piles and its preparing process
06/18/2003CN1111419C Medicine for treating cardiovascular and cerebrovascular apoplexy and applexy aurae and its preparing process
06/18/2003CN1111412C Thrombus clearing soft capsule and preparation technology thereof
06/18/2003CN1111405C Use of piracetam in preparation and for preventing and curing intracranial hypertension
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579978 Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
06/17/2003US6579953 Graft polymers; improved flowability, greater hardness and less friability
06/17/2003US6579902 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579887 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/17/2003US6579858 Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
06/17/2003US6579853 For inhibiting apoptosis or apoptosis-like cell death
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579534 Mixture of soy protein and isoflavone
06/17/2003US6579523 Transplants for myocardial scars
06/17/2003US6579313 Methods for implanting cells
06/17/2003CA2307553C Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
06/14/2003CA2364985A1 Imidazo(2,1-b)thiadiazole sulfonamides
06/12/2003WO2003048360A1 NOVEL PROTEINS BINDING TO MAMMALIAN TARGET OF RAPAMYCIN (mTOR) AND GENES THEREOF
06/12/2003WO2003048358A1 Adipocyte differentiation-associated gene and protein
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048165A1 ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048154A1 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003WO2003048130A2 Peroxisome proliferator activated receptor agonists
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003048106A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003WO2003047625A1 Neural transmission promoters
06/12/2003WO2003047624A1 Cell migration inhibitor
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047609A1 A topical anti-itch formulation and a process for the preparation thereof
06/12/2003WO2003047607A1 Medicinal compositions containing human amnion-origin cells
06/12/2003WO2003047603A2 Breathable gas mixtures to change body temperature
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003047588A1 Kit for reducing aching caused by pde-v inhibitors
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047574A1 Pharmaceutical composition comprising a derivative of 5-phenoxyalkyl-2,4-thiazolidinedione type and a 4-oxobutanoic acid
06/12/2003WO2003047573A1 Insulin resistance improving agents
06/12/2003WO2003047570A1 Benzazole derivatives for the treatment of scleroderma
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047561A1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
06/12/2003WO2003047519A2 'compressed annular tablet with molded triturate tablet for oral and intraoral'
06/12/2003WO2003047517A2 Novel-n-[4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa
06/12/2003WO2003047367A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003005962A3 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002064094A3 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/12/2003WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
06/12/2003WO2002008389A9 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
06/12/2003WO2001088126A8 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
06/12/2003WO2001054677A9 Ace inhibitor-vasopressin antagonist combinations
06/12/2003WO2000040737A9 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
06/12/2003US20030109917 Stent vascular intervention device and method
06/12/2003US20030109813 Energy-activated targeted cancer therapy
06/12/2003US20030109743 Cardiovascular disorders
06/12/2003US20030109700 Antilipemic agents, anticholesterol agents, cardiovascular disorders, antiischemic agents
06/12/2003US20030109688 Purification using cationic ion exchange resins
1 ... 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 ... 1595